Pressure BioSciences Inc.

PBIO on OTCQBToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
4.11US -0.89/-17.80%1,6360.70 / 11.524.75 M

Contact Information

Pressure BioSciences Inc.

Headquarters:
14 Norfolk Avenue,
South Easton, Massachusetts
USA, 02375
Tel: (508) 230-1828
Fax: (508) 230-1829
Email: Send a message
Website: Visit website
For more information...
Lead: Shushu Feng

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology ("UST") to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively prepared using existing technologies. 

Richard T. Schumacher - President and Chief Executive Officer

Edmund Ting, Ph.D. - Senior Vice President of Engineering

Nathan P. Lawrence, Ph.D. - Vice President of Marketing and Sales

Alexander Lazarev, Ph.D. - Vice President of Research and Development

Joseph L. Damasio Jr. - Vice President of Finance and Chief Financial Officer

Jeffrey N. Peterson - Chairman of the Board

Richard T. Schumacher - Director

Vito J. Mangiardi - Director

Kevin A. Pollack - Director

Michael S. Urdea - Director

Stock Information

Company Overview

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology ("UST") to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively prepared using existing technologies. 

Management

Richard T. Schumacher - President and Chief Executive Officer

Edmund Ting, Ph.D. - Senior Vice President of Engineering

Nathan P. Lawrence, Ph.D. - Vice President of Marketing and Sales

Alexander Lazarev, Ph.D. - Vice President of Research and Development

Joseph L. Damasio Jr. - Vice President of Finance and Chief Financial Officer

Board of Directors

Jeffrey N. Peterson - Chairman of the Board

Richard T. Schumacher - Director

Vito J. Mangiardi - Director

Kevin A. Pollack - Director

Michael S. Urdea - Director

Contact Information

Headquarters:
14 Norfolk Avenue,
South Easton, Massachusetts
02375, USA
Telephone: (508) 230-1828
Fax: (508) 230-1829
Email: Send a message
Website: Visit website